Total Payments
$6,823
2024 Payments
$2,150
Companies
52
Transactions
428
Medicare Patients
324
Medicare Billing
$20,947
Payment Breakdown by Category
Food & Beverage$6,711 (98.4%)
Education$111.70 (1.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,711 | 426 | 98.4% |
| Education | $111.70 | 2 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $888.45 | 88 | $0 (2024) |
| Novo Nordisk Inc | $859.46 | 67 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $742.70 | 42 | $0 (2024) |
| PFIZER INC. | $412.58 | 25 | $0 (2024) |
| Lilly USA, LLC | $398.01 | 25 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $361.45 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $234.51 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $178.44 | 13 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $165.84 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $146.42 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,150 | 128 | ABBVIE INC. ($265.72) |
| 2023 | $1,732 | 107 | ABBVIE INC. ($225.70) |
| 2022 | $1,405 | 93 | Novo Nordisk Inc ($223.45) |
| 2021 | $1,535 | 100 | Novo Nordisk Inc ($265.93) |
All Payment Transactions
428 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Obesity | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.51 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: Obesity | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: VACCINES | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: VACCINES | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.04 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Oncology | ||||||
| 11/27/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: VTE | ||||||
| 11/22/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PENBRAYA | Food and Beverage | In-kind items and services | $2.93 | General |
| Category: VACCINES | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: VACCINE | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $8.62 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $9.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $2.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.34 | General |
| Category: Obesity | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: PAIN | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $0.77 | General |
| Category: PAIN | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.94 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 96 | 130 | $17,185 | $7,039 |
| 2022 | 5 | 86 | 112 | $12,540 | $6,085 |
| 2021 | 5 | 84 | 106 | $13,420 | $5,006 |
| 2020 | 3 | 58 | 69 | $9,605 | $2,817 |
Total Patients
324
Total Services
417
Medicare Billing
$20,947
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 43 | $8,170 | $3,060 | 37.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 20 | 20 | $3,350 | $2,083 | 62.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 30 | $4,650 | $1,453 | 31.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 18 | 18 | $540.00 | $263.52 | 48.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 12 | 19 | $475.00 | $180.88 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 41 | $6,560 | $2,856 | 43.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 19 | 19 | $2,850 | $2,055 | 72.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 14 | $2,100 | $722.60 | 34.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 16 | 16 | $480.00 | $240.24 | 50.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 13 | 22 | $550.00 | $210.83 | 38.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 37 | $5,945 | $1,942 | 32.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 16 | 16 | $2,375 | $1,763 | 74.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 28 | $4,090 | $999.67 | 24.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 12 | 12 | $360.00 | $183.36 | 50.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 13 | 13 | $650.00 | $117.60 | 18.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 29 | 37 | $5,920 | $1,271 | 21.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 11 | 11 | $1,375 | $1,043 | 75.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 21 | $2,310 | $502.64 | 21.8% |
About Allison Boonie, NP-C
Allison Boonie, NP-C is a Family healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/25/2014. The National Provider Identifier (NPI) number assigned to this provider is 1174948384.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Allison Boonie, NP-C has received a total of $6,823 in payments from pharmaceutical and medical device companies, with $2,150 received in 2024. These payments were reported across 428 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($6,711).
As a Medicare-enrolled provider, Boonie has provided services to 324 Medicare beneficiaries, totaling 417 services with total Medicare billing of $20,947. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Grand Rapids, MI
- Active Since 02/25/2014
- Last Updated 02/25/2014
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1174948384
Products in Payments
- VRAYLAR (Drug) $537.58
- FARXIGA (Drug) $469.13
- Wegovy (Drug) $333.73
- JARDIANCE (Drug) $280.86
- NURTEC ODT (Drug) $270.57
- UBRELVY (Drug) $231.26
- Ozempic (Drug) $220.49
- MOUNJARO (Drug) $207.11
- BREZTRI (Drug) $206.48
- Rybelsus (Drug) $204.04
- REXULTI (Drug) $174.06
- XIFAXAN (Drug) $165.84
- ELIQUIS (Drug) $153.92
- Cologuard Collection Kit (Device) $134.91
- QULIPTA (Drug) $119.61
- Kerendia (Drug) $111.69
- JORNAY PM (Drug) $109.39
- ENTRESTO (Drug) $86.77
- TRINTELLIX (Drug) $83.62
- TRELEGY ELLIPTA (Drug) $81.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Grand Rapids
Kelsey Prince, Fnp, FNP
Family — Payments: $37,420
Family $37,420
Marlee Bogema, Fnp, FNP
Family — Payments: $6,399
Family $6,399
Mrs. Lisa Teunissen, Np, NP
Family — Payments: $5,883
Family $5,883
Maria Kurlenda
Family — Payments: $5,861
Family $5,861
Karole Murphy, Np, NP
Family — Payments: $5,559
Family $5,559
Ms. Vicki Hahn, N.p, N.P
Family — Payments: $4,766
Family $4,766